News Industry News New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes September 15, 2017
News Industry News Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers September 15, 2016
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
News Industry News The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin) July 09, 2015
News Industry News Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients May 07, 2015